Abstract
Background The Global Initiative for Asthma (GINA) report sets out updated evidence-based strategy for asthma management. Little is known about how this report is perceived and implemented in low-income and middle-income countries (LMICs) like Nigeria. We explored the experiences of asthma management as informed by the current GINA guideline among doctors in Lagos, Nigeria.
Methods Using a qualitative research approach, in-depth interviews were conducted among doctors in Lagos, Nigeria to explore their experiences of asthma management in the context of the current GINA report. The thematic framework approach was used for data analysis.
Results Eleven doctors (five general practitioners (GPs) and six Family Physicians (FPs) took part. Four overarching themes were identified:
Knowledge of, and attitude towards the GINA strategy: Whilst most doctors were aware of the existence of the GINA report, there was limited knowledge about its content including current recommendations for mild asthma treatment.
Asthma diagnosis and treatment: There was limited access to lung function testing facilities and its role in asthma diagnosis was underappreciated.
Barriers to managing asthma according to GINA recommendations: These included complexity of the GINA report, unavailability and unaffordability of asthma medicines and poor patient adherence to medications, driven by socio-cultural factors.
Enablers of GINA-recommended asthma management: Improvement in asthma education for doctors and the general population and better access to diagnostic tests and medicines.
Conclusion Whilst there was awareness of the existence of the GINA report, there was limited knowledge about its content and several barriers to its implementation were reported. Education about the GINA report, investment in diagnostic and treatment services and simplification of recommendations were identified as possible solutions.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors received no funding for this work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval was obtained from the Masters Research Ethics Committee (MREC) of Liverpool School of Tropical Medicine (LSTM) (APP No.:GH21(01)); and the Lagos University Teaching Hospital (LUTH), Lagos, Nigeria (Assigned No.: ADM/DCST/HREC/APP/4046).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data will be available from the corresponding author on reasonable request.
Abbreviations
- CRD
- Chronic respiratory diseases
- DALYs
- Disability Adjusted Life Years
- FPs
- Family physicians
- GPs
- General Practitioners
- GINA
- Global Initiative for Asthma
- ICS
- Inhaled corticosteroids
- LMIC
- Low-income and Middle-Income Countries
- NCD
- Non-communicable disease
